-
1
-
-
84871099014
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
-
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2197-2223
-
-
Murray, C.J.1
Vos, T.2
Lozano, R.3
Naghavi, M.4
Flaxman, A.D.5
Michaud, C.6
Ezzati, M.7
Shibuya, K.8
Salomon, J.A.9
Abdalla, S.10
-
2
-
-
0141920503
-
Burden of major musculoskeletal conditions
-
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646-56.
-
(2003)
Bull World Health Organ
, vol.81
, Issue.9
, pp. 646-656
-
-
Woolf, A.D.1
Pfleger, B.2
-
3
-
-
84919631358
-
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
-
Bruyere O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253-63.
-
(2014)
Semin Arthritis Rheum
, vol.44
, Issue.3
, pp. 253-263
-
-
Bruyere, O.1
Cooper, C.2
Pelletier, J.P.3
Branco, J.4
Luisa Brandi, M.5
Guillemin, F.6
Hochberg, M.C.7
Kanis, J.A.8
Kvien, T.K.9
Martel-Pelletier, J.10
-
4
-
-
84875410203
-
Current interventions in the management of knee osteoarthritis
-
Bhatia D, Bejarano T, Novo M. Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci. 2013;5(1):30-8.
-
(2013)
J Pharm Bioallied Sci
, vol.5
, Issue.1
, pp. 30-38
-
-
Bhatia, D.1
Bejarano, T.2
Novo, M.3
-
5
-
-
10744224265
-
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
-
Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145-55.
-
(2003)
Ann Rheum Dis
, vol.62
, Issue.12
, pp. 1145-1155
-
-
Jordan, K.M.1
Arden, N.K.2
Doherty, M.3
Bannwarth, B.4
Bijlsma, J.W.5
Dieppe, P.6
Gunther, K.7
Hauselmann, H.8
Herrero-Beaumont, G.9
Kaklamanis, P.10
-
6
-
-
84859773681
-
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
-
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-74.
-
(2012)
Arthritis Care Res (Hoboken)
, vol.64
, Issue.4
, pp. 465-474
-
-
Hochberg, M.C.1
Altman, R.D.2
April, K.T.3
Benkhalti, M.4
Guyatt, G.5
McGowan, J.6
Towheed, T.7
Welch, V.8
Wells, G.9
Tugwell, P.10
-
7
-
-
84896690278
-
OARSI guidelines for the non-surgical management of knee osteoarthritis
-
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-88.
-
(2014)
Osteoarthritis Cartilage
, vol.22
, Issue.3
, pp. 363-388
-
-
McAlindon, T.E.1
Bannuru, R.R.2
Sullivan, M.C.3
Arden, N.K.4
Berenbaum, F.5
Bierma-Zeinstra, S.M.6
Hawker, G.A.7
Henrotin, Y.8
Hunter, D.J.9
Kawaguchi, H.10
-
8
-
-
84960124248
-
Paracetamol: not as safe as we thought? A systematic literature review of observational studies
-
Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, Doherty M, Zhang W, Birrell F, Porcheret M, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552-9.
-
(2016)
Ann Rheum Dis
, vol.75
, Issue.3
, pp. 552-559
-
-
Roberts, E.1
Delgado Nunes, V.2
Buckner, S.3
Latchem, S.4
Constanti, M.5
Miller, P.6
Doherty, M.7
Zhang, W.8
Birrell, F.9
Porcheret, M.10
-
9
-
-
33344461287
-
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
-
Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795-808.
-
(2006)
N Engl J Med
, vol.354
, Issue.8
, pp. 795-808
-
-
Clegg, D.O.1
Reda, D.J.2
Harris, C.L.3
Klein, M.A.4
O'Dell, J.R.5
Hooper, M.M.6
Bradley, J.D.7
Bingham, C.O.8
Weisman, M.H.9
Jackson, C.G.10
-
10
-
-
84954371655
-
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
-
Hochberg MC, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Domenech G, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37-44.
-
(2016)
Ann Rheum Dis
, vol.75
, Issue.1
, pp. 37-44
-
-
Hochberg, M.C.1
Martel-Pelletier, J.2
Monfort, J.3
Moller, I.4
Castillo, J.R.5
Arden, N.6
Berenbaum, F.7
Blanco, F.J.8
Conaghan, P.G.9
Domenech, G.10
-
12
-
-
84929590566
-
Discrepancies in composition and biological effects of different formulations of chondroitin sulfate
-
Martel-Pelletier J, Farran A, Montell E, Verges J, Pelletier JP. Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. Molecules. 2015;20(3):4277-89.
-
(2015)
Molecules
, vol.20
, Issue.3
, pp. 4277-4289
-
-
Martel-Pelletier, J.1
Farran, A.2
Montell, E.3
Verges, J.4
Pelletier, J.P.5
-
13
-
-
59649095045
-
Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial
-
Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(2):524-33.
-
(2009)
Arthritis Rheum
, vol.60
, Issue.2
, pp. 524-533
-
-
Kahan, A.1
Uebelhart, D.2
Vathaire, F.3
Delmas, P.D.4
Reginster, J.Y.5
-
14
-
-
14944363294
-
Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial
-
Michel BA, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, Uebelhart D. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52(3):779-86.
-
(2005)
Arthritis Rheum
, vol.52
, Issue.3
, pp. 779-786
-
-
Michel, B.A.1
Stucki, G.2
Frey, D.3
Vathaire, F.4
Vignon, E.5
Bruehlmann, P.6
Uebelhart, D.7
-
15
-
-
1842635731
-
Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo
-
Uebelhart D, Malaise M, Marcolongo R, DeVathaire F, Piperno M, Mailleux E, Fioravanti A, Matoso L, Vignon E. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage. 2004;12(4):269-76.
-
(2004)
Osteoarthritis Cartilage
, vol.12
, Issue.4
, pp. 269-276
-
-
Uebelhart, D.1
Malaise, M.2
Marcolongo, R.3
DeVathaire, F.4
Piperno, M.5
Mailleux, E.6
Fioravanti, A.7
Matoso, L.8
Vignon, E.9
-
16
-
-
79955794264
-
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
-
Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M, Pelletier JP. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis. 2011;70(6):982-9.
-
(2011)
Ann Rheum Dis
, vol.70
, Issue.6
, pp. 982-989
-
-
Wildi, L.M.1
Raynauld, J.P.2
Martel-Pelletier, J.3
Beaulieu, A.4
Bessette, L.5
Morin, F.6
Abram, F.7
Dorais, M.8
Pelletier, J.P.9
-
17
-
-
30744472413
-
Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants
-
Chan PS, Caron JP, Orth MW. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res. 2005;66(11):1870-6.
-
(2005)
Am J Vet Res
, vol.66
, Issue.11
, pp. 1870-1876
-
-
Chan, P.S.1
Caron, J.P.2
Orth, M.W.3
-
18
-
-
37848999867
-
Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts
-
Tat SK, Pelletier JP, Vergés J, Montell E, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts. Arthritis Res Ther. 2007;9:R117.
-
(2007)
Arthritis Res Ther
, vol.9
, pp. R117
-
-
Tat, S.K.1
Pelletier, J.P.2
Vergés, J.3
Montell, E.4
Lajeunesse, D.5
Fahmi, H.6
Lavigne, M.7
Martel-Pelletier, J.8
-
20
-
-
70349335800
-
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
-
du Souich P, Garcia AG, Verges J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009;13(8A):1451-63.
-
(2009)
J Cell Mol Med
, vol.13
, Issue.8 A
, pp. 1451-1463
-
-
Souich, P.1
Garcia, A.G.2
Verges, J.3
Montell, E.4
-
21
-
-
77953775543
-
Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review
-
Martel-Pelletier J, Kwan Tat S, Pelletier JP. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review. Osteoarthritis Cartilage. 2010;18 Suppl 1:S7-11.
-
(2010)
Osteoarthritis Cartilage
, vol.18
, pp. S7-11
-
-
Martel-Pelletier, J.1
Kwan Tat, S.2
Pelletier, J.P.3
-
22
-
-
78649452031
-
An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis
-
Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Choquette D, Haraoui B, Abram F, Pelletier JP. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum. 2010;40(3):185-92.
-
(2010)
Semin Arthritis Rheum
, vol.40
, Issue.3
, pp. 185-192
-
-
Raynauld, J.P.1
Martel-Pelletier, J.2
Beaulieu, A.3
Bessette, L.4
Morin, F.5
Choquette, D.6
Haraoui, B.7
Abram, F.8
Pelletier, J.P.9
-
23
-
-
0033507971
-
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial
-
Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc. 1999;74(11):1095-105.
-
(1999)
Mayo Clin Proc
, vol.74
, Issue.11
, pp. 1095-1105
-
-
Bensen, W.G.1
Fiechtner, J.J.2
McMillen, J.I.3
Zhao, W.W.4
Yu, S.S.5
Woods, E.M.6
Hubbard, R.C.7
Isakson, P.C.8
Verburg, K.M.9
Geis, G.S.10
-
24
-
-
0022465236
-
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
-
Altman RD, Asch E, Bloch DA, Bole G, Borenstein D, Brandt KD, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039-49.
-
(1986)
Arthritis Rheum
, vol.29
, pp. 1039-1049
-
-
Altman, R.D.1
Asch, E.2
Bloch, D.A.3
Bole, G.4
Borenstein, D.5
Brandt, K.D.6
Christy, W.7
Cooke, T.D.8
Greenwald, R.9
Hochberg, M.10
-
25
-
-
62949246527
-
Radiological assessment of osteoarthosis
-
Kellgren JH, Lawrence JS. Radiological assessment of osteoarthosis. Ann Rheum Dis. 1957;16:494-502.
-
(1957)
Ann Rheum Dis
, vol.16
, pp. 494-502
-
-
Kellgren, J.H.1
Lawrence, J.S.2
-
26
-
-
84903455882
-
Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial
-
Lohmander LS, Hellot S, Dreher D, Krantz EF, Kruger DS, Guermazi A, Eckstein F. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(7):1820-31.
-
(2014)
Arthritis Rheumatol
, vol.66
, Issue.7
, pp. 1820-1831
-
-
Lohmander, L.S.1
Hellot, S.2
Dreher, D.3
Krantz, E.F.4
Kruger, D.S.5
Guermazi, A.6
Eckstein, F.7
-
27
-
-
67449128722
-
Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI
-
Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, Beaulieu AD, Abram F, Dorais M, Vignon E, et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis. 2009;68(6):938-47.
-
(2009)
Ann Rheum Dis
, vol.68
, Issue.6
, pp. 938-947
-
-
Raynauld, J.P.1
Martel-Pelletier, J.2
Bias, P.3
Laufer, S.4
Haraoui, B.5
Choquette, D.6
Beaulieu, A.D.7
Abram, F.8
Dorais, M.9
Vignon, E.10
-
28
-
-
84876699324
-
Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons
-
Wildi LM, Martel-Pelletier J, Abram F, Moser T, Raynauld JP, Pelletier JP. Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons. Arthritis Care Res (Hoboken). 2013;65(5):686-94.
-
(2013)
Arthritis Care Res (Hoboken)
, vol.65
, Issue.5
, pp. 686-694
-
-
Wildi, L.M.1
Martel-Pelletier, J.2
Abram, F.3
Moser, T.4
Raynauld, J.P.5
Pelletier, J.P.6
-
29
-
-
50849121680
-
A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI
-
Pelletier JP, Raynauld JP, Abram F, Haraoui B, Choquette D, Martel-Pelletier J. A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI. Osteoarthritis Cartilage. 2008;16 Suppl 3:S8-13.
-
(2008)
Osteoarthritis Cartilage
, vol.16
, pp. S8-13
-
-
Pelletier, J.P.1
Raynauld, J.P.2
Abram, F.3
Haraoui, B.4
Choquette, D.5
Martel-Pelletier, J.6
-
30
-
-
10744224242
-
Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes
-
Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Labonté F, Beaudoin G, de Guise JA, Bloch DA, Choquette D, Haraoui B, Altman RD, et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum. 2004;50:476-87.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 476-487
-
-
Raynauld, J.P.1
Martel-Pelletier, J.2
Berthiaume, M.J.3
Labonté, F.4
Beaudoin, G.5
Guise, J.A.6
Bloch, D.A.7
Choquette, D.8
Haraoui, B.9
Altman, R.D.10
-
31
-
-
0043268073
-
Computer-aided method for quantification of cartilage thickness and volume changes using MRI: validation study using a synthetic model
-
Kauffmann C, Gravel P, Godbout B, Gravel A, Beaudoin G, Raynauld JP, Martel-Pelletier J, Pelletier JP, de Guise JA. Computer-aided method for quantification of cartilage thickness and volume changes using MRI: validation study using a synthetic model. IEEE Trans Biomed Eng. 2003;50(8):978-88.
-
(2003)
IEEE Trans Biomed Eng
, vol.50
, Issue.8
, pp. 978-988
-
-
Kauffmann, C.1
Gravel, P.2
Godbout, B.3
Gravel, A.4
Beaudoin, G.5
Raynauld, J.P.6
Martel-Pelletier, J.7
Pelletier, J.P.8
Guise, J.A.9
-
32
-
-
0038103579
-
Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees
-
Raynauld JP, Kauffmann C, Beaudoin G, Berthiaume MJ, de Guise JA, Bloch DA, Camacho F, Godbout B, Altman RD, Hochberg M, et al. Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthritis Cartilage. 2003;11(5):351-60.
-
(2003)
Osteoarthritis Cartilage
, vol.11
, Issue.5
, pp. 351-360
-
-
Raynauld, J.P.1
Kauffmann, C.2
Beaudoin, G.3
Berthiaume, M.J.4
Guise, J.A.5
Bloch, D.A.6
Camacho, F.7
Godbout, B.8
Altman, R.D.9
Hochberg, M.10
-
33
-
-
77956583756
-
Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging
-
Li W, Abram F, Pelletier JP, Raynauld JP, Dorais M, d'Anjou MA, Martel-Pelletier J. Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging. Arthritis Res Ther. 2010;12(5):R173.
-
(2010)
Arthritis Res Ther
, vol.12
, Issue.5
, pp. R173
-
-
Li, W.1
Abram, F.2
Pelletier, J.P.3
Raynauld, J.P.4
Dorais, M.5
d'Anjou, M.A.6
Martel-Pelletier, J.7
-
34
-
-
34247551198
-
Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes
-
Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Beaudoin G, Choquette D, Haraoui B, Tannenbaum H, Meyer JM, Beary JF, Cline GA, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther. 2006;8(1):R21.
-
(2006)
Arthritis Res Ther
, vol.8
, Issue.1
, pp. R21
-
-
Raynauld, J.P.1
Martel-Pelletier, J.2
Berthiaume, M.J.3
Beaudoin, G.4
Choquette, D.5
Haraoui, B.6
Tannenbaum, H.7
Meyer, J.M.8
Beary, J.F.9
Cline, G.A.10
-
35
-
-
84924911826
-
Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents
-
Gallagher B, Tjoumakaris FP, Harwood MI, Good RP, Ciccotti MG, Freedman KB. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med. 2015;43(3):734-44.
-
(2015)
Am J Sports Med
, vol.43
, Issue.3
, pp. 734-744
-
-
Gallagher, B.1
Tjoumakaris, F.P.2
Harwood, M.I.3
Good, R.P.4
Ciccotti, M.G.5
Freedman, K.B.6
-
36
-
-
84873648604
-
Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?
-
Hochberg M, Chevalier X, Henrotin Y, Hunter DJ, Uebelhart D. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? Curr Med Res Opin. 2013;29(3):259-67.
-
(2013)
Curr Med Res Opin
, vol.29
, Issue.3
, pp. 259-267
-
-
Hochberg, M.1
Chevalier, X.2
Henrotin, Y.3
Hunter, D.J.4
Uebelhart, D.5
-
37
-
-
77953736595
-
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration
-
Hochberg MC. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage. 2010;18 Suppl 1:S28-31.
-
(2010)
Osteoarthritis Cartilage
, vol.18
, pp. S28-31
-
-
Hochberg, M.C.1
-
38
-
-
73649146195
-
Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis
-
Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30(3):357-63.
-
(2010)
Rheumatol Int
, vol.30
, Issue.3
, pp. 357-363
-
-
Lee, Y.H.1
Woo, J.H.2
Choi, S.J.3
Ji, J.D.4
Song, G.G.5
-
39
-
-
84926454571
-
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
-
Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, March L, Edmonds J, Norton R, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015;74(5):851-8.
-
(2015)
Ann Rheum Dis
, vol.74
, Issue.5
, pp. 851-858
-
-
Fransen, M.1
Agaliotis, M.2
Nairn, L.3
Votrubec, M.4
Bridgett, L.5
Su, S.6
Jan, S.7
March, L.8
Edmonds, J.9
Norton, R.10
-
40
-
-
77957342022
-
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
-
Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675.
-
(2010)
BMJ
, vol.341
-
-
Wandel, S.1
Juni, P.2
Tendal, B.3
Nuesch, E.4
Villiger, P.M.5
Welton, N.J.6
Reichenbach, S.7
Trelle, S.8
-
41
-
-
34247624271
-
Meta-analysis: chondroitin for osteoarthritis of the knee or hip
-
Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, Dieppe PA, Juni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146(8):580-90.
-
(2007)
Ann Intern Med
, vol.146
, Issue.8
, pp. 580-590
-
-
Reichenbach, S.1
Sterchi, R.2
Scherer, M.3
Trelle, S.4
Burgi, E.5
Burgi, U.6
Dieppe, P.A.7
Juni, P.8
-
42
-
-
0038494028
-
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis
-
Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163(13):1514-22.
-
(2003)
Arch Intern Med
, vol.163
, Issue.13
, pp. 1514-1522
-
-
Richy, F.1
Bruyere, O.2
Ethgen, O.3
Cucherat, M.4
Henrotin, Y.5
Reginster, J.Y.6
-
43
-
-
84861821039
-
Interpretation of metaanalyses: pitfalls should be more widely recognized
-
Henrotin YE. Interpretation of metaanalyses: pitfalls should be more widely recognized. J Rheumatol. 2012;39(6):1107-9.
-
(2012)
J Rheumatol
, vol.39
, Issue.6
, pp. 1107-1109
-
-
Henrotin, Y.E.1
-
44
-
-
85047683313
-
Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique
-
Rainsford KD. Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique. J Pharm Pharmacol. 2009;61(10):1263-70.
-
(2009)
J Pharm Pharmacol
, vol.61
, Issue.10
, pp. 1263-1270
-
-
Rainsford, K.D.1
-
45
-
-
84955714059
-
Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: data from the OAI progression cohort
-
Roubille C, Martel-Pelletier J, Abram F, Dorais M, Delorme P, Raynauld JP, Pelletier JP. Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: data from the OAI progression cohort. Semin Arthritis Rheum. 2015;45(3):257-67.
-
(2015)
Semin Arthritis Rheum
, vol.45
, Issue.3
, pp. 257-267
-
-
Roubille, C.1
Martel-Pelletier, J.2
Abram, F.3
Dorais, M.4
Delorme, P.5
Raynauld, J.P.6
Pelletier, J.P.7
-
46
-
-
84883757863
-
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?
-
Pelletier JP, Cooper C, Peterfy C, Reginster JY, Brandi ML, Bruyere O, Chapurlat R, Cicuttini F, Conaghan PG, Doherty M, et al. What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Ann Rheum Dis. 2013;72(10):1594-604.
-
(2013)
Ann Rheum Dis
, vol.72
, Issue.10
, pp. 1594-1604
-
-
Pelletier, J.P.1
Cooper, C.2
Peterfy, C.3
Reginster, J.Y.4
Brandi, M.L.5
Bruyere, O.6
Chapurlat, R.7
Cicuttini, F.8
Conaghan, P.G.9
Doherty, M.10
-
47
-
-
84879141778
-
Total knee replacement as a knee osteoarthritis outcome: predictors derived from a 4 year long-term observation following a randomized clinical trial using chondroitin sulfate
-
Raynauld JP, Martel-Pelletier J, Dorais M, Haraoui B, Choquette D, Abram F, Beaulieu A, Bessette L, Morin F, Wildi LM, et al. Total knee replacement as a knee osteoarthritis outcome: predictors derived from a 4 year long-term observation following a randomized clinical trial using chondroitin sulfate. Cartilage. 2013;4(3):219-26.
-
(2013)
Cartilage
, vol.4
, Issue.3
, pp. 219-226
-
-
Raynauld, J.P.1
Martel-Pelletier, J.2
Dorais, M.3
Haraoui, B.4
Choquette, D.5
Abram, F.6
Beaulieu, A.7
Bessette, L.8
Morin, F.9
Wildi, L.M.10
-
48
-
-
77953809438
-
Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study
-
Moller I, Perez M, Monfort J, Benito P, Cuevas J, Perna C, Domenech G, Herrero M, Montell E, Verges J. Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage. 2010;18 Suppl 1:S32-40.
-
(2010)
Osteoarthritis Cartilage
, vol.18
, pp. S32-40
-
-
Moller, I.1
Perez, M.2
Monfort, J.3
Benito, P.4
Cuevas, J.5
Perna, C.6
Domenech, G.7
Herrero, M.8
Montell, E.9
Verges, J.10
-
49
-
-
84865121703
-
Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum®
-
Schneider H, Maheu E, Cucherat M. Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum®. Open Rheumatol J. 2012;6:183-9.
-
(2012)
Open Rheumatol J
, vol.6
, pp. 183-189
-
-
Schneider, H.1
Maheu, E.2
Cucherat, M.3
-
50
-
-
84930510761
-
Placebo effect in osteoarthritis: Why not use it to our advantage?
-
de Campos GC. Placebo effect in osteoarthritis: Why not use it to our advantage? World J Orthop. 2015;6(5):416-20.
-
(2015)
World J Orthop
, vol.6
, Issue.5
, pp. 416-420
-
-
Campos, G.C.1
-
51
-
-
84879822928
-
A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis
-
Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford). 2013;52(7):1303-12.
-
(2013)
Rheumatology (Oxford)
, vol.52
, Issue.7
, pp. 1303-1312
-
-
Conaghan, P.G.1
Dickson, J.2
Bolten, W.3
Cevc, G.4
Rother, M.5
-
52
-
-
33847420941
-
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
-
Bingham 3rd CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford). 2007;46(3):496-507.
-
(2007)
Rheumatology (Oxford)
, vol.46
, Issue.3
, pp. 496-507
-
-
Bingham, C.O.1
Sebba, A.I.2
Rubin, B.R.3
Ruoff, G.E.4
Kremer, J.5
Bird, S.6
Smugar, S.S.7
Fitzgerald, B.J.8
O'Brien, K.9
Tershakovec, A.M.10
-
53
-
-
4344569331
-
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib
-
Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, Bliddal H, Uebelhart D, Adami S, Navarro F, et al. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis. 2004;63(11):1419-26.
-
(2004)
Ann Rheum Dis
, vol.63
, Issue.11
, pp. 1419-1426
-
-
Tannenbaum, H.1
Berenbaum, F.2
Reginster, J.Y.3
Zacher, J.4
Robinson, J.5
Poor, G.6
Bliddal, H.7
Uebelhart, D.8
Adami, S.9
Navarro, F.10
|